The treatment of XXXX withdrawal.

@entity1 @entity3347 @entity410 @entity101 @entity167 @entity591 @entity14935 @entity1245 @entity3174 @entity1338
Abrupt cessation of regular use of @entity167 in a dependent @entity1 causes a @entity3347 that may range from mild to extremely severe. Most @entity1 require pharmacologic intervention, especially those with severe symptoms. Historically, the pharmacotherapy of @entity167 withdrawal has involved a wide variety of agents. @entity1245 are currently preferred due to their consistently high degree of efficacy and laudable record of safety. In addition, beta blockers and @entity1338 are useful, as both effectively combat the @entity101 and @entity591 commonly associated with withdrawal. They are ineffective as anticonvulsants; however. Opinions differ concerning the best treatment for @entity410 . Prophylaxis with @entity1245 may be all that is required, although some authors advocate the use of @entity3174 for 5 days, especially in @entity1 with a history of prior @entity410 during @entity167 withdrawal. Once established, delirium @entity14935 are difficult to treat. @entity1245 are most commonly used to provide sedation, and extremely large doses may be required. Careful clinical assessment is essential to the proper treatment of @entity1 undergoing @entity167 withdrawal since the coexistence of medical problems may complicate the condition.
